American Society of Hirudotherapy

Transcriptomic Profiling at the Maternal-to-Zygotic Transition in Leech

Basic science published in Genes (2024)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportGenomics & ProteomicsHsaio S et al. · Genes, 2024

Abstract

The glossiphoniid leech, Helobdella austinensis, is an experimentally tractable member of the superphylum, Lophotrochozoa. Its large embryonic cells, stereotyped asymmetric cell divisions and ex vivo development capabilities makes it a favorable model for studying the molecular and cellular events of a representative spiralian. In this study, we focused on a narrow developmental time window of ~6-8 h, comprising stages just prior to and immediately following zygote deposition. Employing RNA-Seq methodology, we identified differentially expressed transcripts at this fundamental ontogenic boundary, known as the maternal-to-zygotic transition (MZT). Gene expression changes were characterized by the massive degradation of maternal RNAs (~45%) coupled with the rapid transcription of ~5000 zygotic genes (~20% of the genome) in the first mitotic cell cycle. The latter transcripts encoded a mixture of cell maintenance and regulatory proteins that predictably influence downstream developmental events.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleResearch Support, U.S. Gov't, Non-P.H.S.Research Support, Non-U.S. Gov't
Indexed MeSH termsZygoteCell DivisionTranscription FactorsGenomeGene Expression Profiling

Summary

RNA-Seq profiling of glossiphoniid leech maternal-to-zygotic transition reveals ~45% maternal RNA degradation coupled with ~5000 zygotic genes (~20% genome) transcribed in first mitotic cell cycle.

Why This Matters for Hirudotherapy

This study utilized RNA-Seq to profile gene expression during the maternal-to-zygotic transition in the glossiphoniid leech, Helobdella austinensis. The researchers characterized fundamental developmental events in this leech species, identifying massive maternal RNA degradation and the rapid transcription of thousands of zygotic genes during early embryonic cell division. While the article involves leeches, its direct relevance to the American Society of Hirudotherapy is limited. The research focuses entirely on the evolutionary and developmental biology of a non-medical leech species and does not investigate the therapeutic use of leeches, hirudotherapy, or the pharmacological properties of the leech secretome relevant to clinical practice.

Citation

Transcriptomic Profiling at the Maternal-to-Zygotic Transition in Leech.

Hsaio S et al. · Genes, 2024

Added to ASH library: May 27, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.